GB371550A - Process for purifying physiologically active substances - Google Patents
Process for purifying physiologically active substancesInfo
- Publication number
- GB371550A GB371550A GB8028/31A GB802831A GB371550A GB 371550 A GB371550 A GB 371550A GB 8028/31 A GB8028/31 A GB 8028/31A GB 802831 A GB802831 A GB 802831A GB 371550 A GB371550 A GB 371550A
- Authority
- GB
- United Kingdom
- Prior art keywords
- product
- precipitate
- per cent
- precipitated
- treated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Removal Of Specific Substances (AREA)
Abstract
Crude extracts containing cardiac substances are purified by precipitating the active substances with heavy metal compounds such as copper, silver, lead or mercury salts, with or without the addition of other salts such as sodium acetate or magnesium salts, and subsequently removing the precipitant. Examples of the invention are as follows: (1) the mother liquor, remaining after the precipitation of blood-sugar level reducing substances with ammonium sulphate from pancreas extract, is mixed with acetone; 500 c.c. of the aqueous layer which forms is diluted to 2 litres, 100 gms. of sodium acetate and 160 c.c. of 40 per cent sodium bisulphite solution added and the mixture boiled; 10 per cent copper sulphate is then added until no more precipitate forms; the liquid is boiled for three minutes, filtered hot, the precipitate suspended in water, slightly acidified and the copper precipitated with hydrogen sulphide; the filtered solution is evaporated in vacuo and the residue dissolved in water, neutralized and standardized: (2) organic phosphorus-containing substances are removed from the product of (1) by precipitation with magnesia mixture, and the filtrate is treated with excess magnesia mixture and ammoniacal silver nitrate; the precipitate is separated, washed with ammonia, suspended in water, and the silver precipitated with hydrochloric acid; the precipitate is filtered off and the filtrate evaporated in vacuo and redissolved: (3) a mother liquor as in (1) is diluted, precipitated with 10 per cent copper sulphate solution in the presence of sodium acetate and sodium bisulphite, and worked up as in (1): (4) the product of the example of Specification 279,445, [Class 81 (i), Disinfecting &c.], is precipitated with 80 per cent copper sulphate solution in the presence of sodium acetate and sodium bisulphite and further worked up as in (1): (5) the product of example (1) of Specification 335,202, [Class 81 (i), Disinfecting &c.], is treated as in (2) : (6) the product of the process of Specification 359,523 is treated as in (1) : (7) the product of example (1) is treated with solid cuprous chloride while boiling and further worked up as in (1) : (8) the product of the example of Specification 279,445 is rendered slightly ammoniacal and precipitated with 25 per cent lead acetate solution, filtered, and the lead removed from the precipitate, ground in water, by treatment with 20 per cent sulphuric acid; traces of lead are removed from the filtrate with hydrogen sulphide: (9) the product of example (1) of Specification 335,202 is treated with mercuric chloride solution and the mercury removed from the precipitate with hydrogen sulphide. Specifications 306,606 and 306,608, [both in Class 81 (i), Disinfecting &c.], also are referred to.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE371550X | 1930-03-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB371550A true GB371550A (en) | 1932-04-28 |
Family
ID=6327171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8028/31A Expired GB371550A (en) | 1930-03-14 | 1931-03-16 | Process for purifying physiologically active substances |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB371550A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2789983A (en) * | 1954-08-03 | 1957-04-23 | Commercial Solvents Corp | Recovery of cycloserine |
-
1931
- 1931-03-16 GB GB8028/31A patent/GB371550A/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2789983A (en) * | 1954-08-03 | 1957-04-23 | Commercial Solvents Corp | Recovery of cycloserine |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2998450A (en) | Process of preparing nu-acetyl-p-amino phenol | |
Smith et al. | Studies on the Polymethylbenzenes. XIII. 1 Mercuration | |
GB371550A (en) | Process for purifying physiologically active substances | |
US2046937A (en) | Process for the preparation of copper compounds from metallic copper | |
US2302204A (en) | Process for the manufacture and purification of uric acid | |
DE616987C (en) | ||
GB579459A (en) | Process for the purification of 4-hydroxycoumarins | |
Ewins | Note on the Isolation of Methylguanidine by the Silver Method | |
US1669328A (en) | Specific antidiabetic principle | |
DE868908C (en) | Process for the production of dithiooxamide (rubean hydrogen) | |
DE909936C (en) | Process for the extraction of active ingredients from flowers of Arnica montana | |
US2361576A (en) | Method of refining a crude 1-naphthylacetic acid | |
US1924073A (en) | Stable ammonium salt of primula saponine | |
US1890373A (en) | Hormone and the process of obtaining same | |
US2631147A (en) | Preparation of medicinal grade sulfamethazine | |
US1798030A (en) | Method for reducing nitroarylarsonic acids | |
DE668576C (en) | Process for the separation and purification of glutathione from aqueous solutions | |
AT132842B (en) | Process for the production of cardiac agents in purified form. | |
DE733809C (en) | Process for the extraction of glycosides from Strophanthus Kombe | |
DE325957C (en) | Process for the production of a copper-tannin-protein compound | |
GB1214093A (en) | Purification of deoxycholic acid | |
DE854957C (en) | Process for the production of amines | |
GB497081A (en) | Improvements in obtaining the antineuritic vitamin | |
SU67225A1 (en) | Method of cleaning technical uric acid | |
DE670098C (en) | Process for the enrichment of biotin |